Prolyl-Hydroxylase Inhibitors
DBCAT006062Pharmacologic class
Compounds that inhibit the action of HYDROXYLASES that act on PROLINE to form HYDROXYPROLINE. A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of April 03, 2026
Which targets do Prolyl-Hydroxylase Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account